BROSSARD, QUEBEC--(Marketwire - June 14, 2011) - Biotonix (2010) Inc. (TSX VENTURE:BTX) ("Biotonix"), a leader in postural health and fitness, today announced that it recently presented its portfolio of posture & fitness solutions to approximately 20 Chief Executive Officers & Presidents of the largest fitness chains in Europe.
"To be able to present to such a selective audience is a great opportunity for Biotonix as it is directly linked to its strategic development plan," said Louise St-Onge, CEO of Biotonix. Through this initiative, the Company is getting exclusive dedicated airtime to discuss the benefits that its solutions can bring in helping to reach body biomechanical equilibrium as well as overall fitness. Biotonix will thereby benefit from a fast track exposure as it pursues its penetration of the fitness market in Europe, a market worth 20 billion USD in annual revenues."
The Company also announced that Livia Masnaghetti, Chair of the Board's Audit Committee, CA, Financial Advisor, Groupe Aeroplan, received 50,000 options at an exercise price of $0.24 and maturing on May 26, 2016.
About EHFA
EHFA is a not-for-profit organization representing the interests of the European health and fitness sector at the EU level with a membership base of almost 10 000 facilities. Its objective is "More people, more active, more often." EHFA is also a standards-setting body and promotes best practices in instruction and training to help combat the inactivity and obesity challenges spreading across Europe. The sector has more than 40 000 facilities, 390 000 exercise professionals across Europe, as well as national associations, operators, suppliers, training providers, and other stakeholders. EHFA also operates the European Register of Exercise Professionals (EREPS).
About Livia Masnaghetti
Livia Masnaghetti is a graduate of McGill University's Faculty of Management and is a member of the Quebec Order of Chartered Accountants and the Canadian Institute of Chartered Accountants. Mrs. Masnaghetti has assisted and continues to assist companies such as Emergis, Groupe Aeroplan and Jazz Income Fund in areas ranging from their Initial Public Offerings to their continuous disclosure obligations and regulatory requirements to financial reporting, tax, technology implementations of financial systems and M&A. She was also an audit and advisory services partner with Raymond Chabot Grant Thornton and an advisor to the Board of Directors of Sofinov, the technology venture capital firm of the Caisse de Dépôt et Placement du Québec.
BIOTONIX PROFILE
Biotonix (TSX VENTURE:BTX) offers innovative health solutions for posture correction and fitness using a web-based imaging software technology. Biotonix is currently developing novel orthotics for the back and foot, also geared specifically toward improving posture. For more information please visit www.biotonix.com
BIOTONIX'S FORWARD-LOOKING STATEMENTS
This press release contains forward-looking statements that reflect the Company's current expectation regarding future events. There is a risk that expectations and forward looking statements will not prove to be accurate. Readers are cautioned not to place undue reliance on these forward looking statements as they involve risks and uncertainties, which could make actual results differ materially from those projected herein and depend on a number of factors including, but not limited to, no history of profitability, future financing, intellectual property and patents, key personnel, competitive marketplace, technology obsolescence, share price volatility and other risks detailed from time to time in the Company's filings. While Biotonix anticipates that subsequent events and developments may cause its views to change, Biotonix specifically disclaims any obligation to update these forward looking statements, unless obligated to do so by applicable securities laws
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Contact Information:
Louise St-Onge
CEO
514.840.0004 ext 229
stongel@biotonix.com
www.biotonix.com